"ADE Fibrinogen/RBC" Ratio on Mortality and Outcome in Massive Transfusion Patients — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

"ADE Fibrinogen/RBC" Ratio on Mortality and Outcome in Massive Transfusion Patients — Stella

Home/Massive Transfusion/

View on ClinicalTrials.gov

Recruiting

Back to Massive Transfusion trials

Trial locations(1 site)

Turkey (Türkiye)

Ankara Bilkent city hospital, Ankara, çankaya

Key details

Sponsor

Ankara City Hospital Bilkent

Collaborators

Istanbul University, Ondokuz Mayıs University

Enrollment target

~1,679 participants

Started

November 2023

Primary completion

October 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated December 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.